Advertisement
Screener

ACCELERON PHARMA INC. Accrued Liabilities, Current

ACCELERON PHARMA INC. Accrued Liabilities, Current

ACCELERON PHARMA INC. had Accrued Liabilities, Current of $44.12 million as of 2021-09-30, per its 10-Q filed 2021-11-04.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current

us-gaap:AccruedLiabilitiesCurrent · last filed 2021-11-04

  • 2021-09-30: Accrued Liabilities, Current $44.12M.
  • 2021-06-30: Accrued Liabilities, Current $42.49M.
  • 2021-03-31: Accrued Liabilities, Current $38.07M.
  • 2020-12-31: Accrued Liabilities, Current $44.68M.
Period endAccrued Liabilities, Current
2021-09-30$44.12M
10-Q · filed 2021-11-04
2021-06-30$42.49M
10-Q · filed 2021-08-05
2021-03-31$38.07M
10-Q · filed 2021-05-06
2020-12-31$44.68M
10-Q · filed 2021-11-04
2020-09-30$21.92M
10-Q · filed 2020-11-05
2020-06-30$17.97M
10-Q · filed 2020-08-06
2020-03-31$18.19M
10-Q · filed 2020-05-11
2019-12-31$24.89M
10-K · filed 2021-02-25
2019-09-30$23.82M
10-Q · filed 2019-11-06
2019-06-30$16.76M
10-Q · filed 2019-08-05
2019-03-31$13.80M
10-Q · filed 2019-05-09
2018-12-31$18.21M
10-K · filed 2020-02-27
2018-09-30$13.14M
10-Q · filed 2018-10-30
2018-06-30$13.11M
10-Q · filed 2018-08-02
2018-03-31$11.08M
10-Q · filed 2018-05-08
2017-12-31$14.94M
10-K · filed 2019-02-27
2017-09-30$14.14M
10-Q · filed 2017-11-07
2017-06-30$11.37M
10-Q · filed 2017-08-03
2017-03-31$12.97M
10-Q · filed 2017-05-08
2016-12-31$13.25M
10-K · filed 2018-02-27
2016-09-30$12.81M
10-Q · filed 2016-11-03
2016-06-30$11.82M
10-Q · filed 2016-08-04
2016-03-31$12.68M
10-Q · filed 2016-05-05
2015-12-31$12.40M
10-K · filed 2017-03-01
2015-09-30$8.97M
10-Q · filed 2015-11-04
2015-06-30$8.38M
10-Q · filed 2015-08-06
2015-03-31$6.69M
10-Q · filed 2015-05-07
2014-12-31$6.85M
10-K · filed 2016-02-25
2014-09-30$5.94M
10-Q · filed 2014-11-07
2014-06-30$6.47M
10-Q · filed 2014-08-12
2014-03-31$4.66M
10-Q · filed 2014-05-15
2013-12-31$6.93M
10-K · filed 2015-03-02
2013-09-30$5.13M
10-Q · filed 2013-11-14
2012-12-31$6.15M
10-K · filed 2014-03-17